Evidence map›Paper›PMID 33916234›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Application of Supervised Machine Learning to Recognize Competent Level and Mixed Antinuclear Antibody Patterns Based on ICAP International Consensus.

Yi-Da Wu, Ruey-Kai Sheu, Chih-Wei Chung, Yen-Ching Wu, Chiao-Chi Ou, Chien-Wen Hsiao, Huang-Chen Chang, Ying-Chieh Huang, Yi-Ming Chen, Win-Tsung Lo and 8 more

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Biomarkers in Systemic Sclerosis: An Overview.Current issues in molecular biology · 2023
    Review
  11. Article
  12. Article
  13. Artificial Intelligence and Deep Learning for Rheumatologists.Arthritis & rheumatology (Hoboken, N.J.) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Yi-Da WuDivision of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung 40705, Taiwan.ORCID 0000-0001-8440-9003
Ruey-Kai SheuDepartment of Computer Science, Tunghai University, Taichung 407224, Taiwan.ORCID 0000-0002-3014-8095
Chih-Wei ChungAI Center, Tunghai University, Taichung 407224, Taiwan.
Yen-Ching WuDivision of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Chiao-Chi OuDivision of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Chien-Wen HsiaoDivision of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Huang-Chen ChangDivision of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Ying-Chieh HuangDivision of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Yi-Ming ChenDivision of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung 40705, Taiwan.ORCID 0000-0001-7593-3065
Win-Tsung LoDepartment of Computer Science, Tunghai University, Taichung 407224, Taiwan.
Lun-Chi ChenCollege of Engineering, Tunghai University, Taichung 407224, Taiwan.ORCID 0000-0002-8449-7872
Chien-Chung HuangDepartment of Computer Science, Tunghai University, Taichung 407224, Taiwan.
Tsu-Yi HsiehDivision of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Wen-Nan HuangDivision of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Tsai-Hung YenDivision of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Yun-Wen ChenDivision of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung 40705, Taiwan.ORCID 0000-0002-6243-5355
Chia-Yu ChenDepartment of Computer Science, Tunghai University, Taichung 407224, Taiwan.
Yi-Hsing ChenDivision of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung 40705, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntinuclear antibody pattern recognition is vital for autoimmune disease diagnosis but labor-intensive for manual interpretation. To develop an automated pattern recognition system, we established machine learning models based on the International Consensus on Antinuclear Antibody Patterns (ICAP) at a competent level, mixed patterns recognition, and evaluated their consistency with human reading.

methods51,694 human epithelial cells (HEp-2) cell images with patterns assigned by experienced medical technologists collected in a medical center were used to train six machine learning algorithms and were compared by their performance. Next, we choose the best performing model to test the consistency with five experienced readers and two beginners.

resultsThe mean F1 score in each classification of the best performing model was 0.86 evaluated by Testing Data 1. For the inter-observer agreement test on Testing Data 2, the average agreement was 0.849 (κ) among five experienced readers, 0.844 between the best performing model and experienced readers, 0.528 between experienced readers and beginners. The results indicate that the proposed model outperformed beginners and achieved an excellent agreement with experienced readers.

conclusionsThis study demonstrated that the developed model could reach an excellent agreement with experienced human readers using machine learning methods.

Indexed as

antinuclear antibodyartificial intelligenceHep-2 cellICAPmachine learning

Identifiers

PMID33916234
PMCPMC8066559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.